A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing radiotherapy for prostate cancer, providing key insights for optimizing patient care.
BioNTech inks cancer deal with Chinese biotech; Eikon, CASI buy Cleave Therapeutics’ assets
BioNTech has reached a research and option agreement with Biotheus for two antibody candidates. Biotheus announced the deal Wednesday. It will grant BioNTech exclusive worldwide